Published in J Clin Endocrinol Metab on October 01, 1979
Limitations of creatinine as a filtration marker in glomerulopathic patients. Kidney Int (1985) 4.76
Binding of thyroglobulin and thyroglobulin-antithyroglobulin immune complex to extraocular muscle membrane. Endocrinology (1974) 1.92
Appearance of Graves' disease on orbital computed tomography. J Comput Assist Tomogr (1979) 1.67
Supervoltage orbital radiotherapy for Graves' ophthalmopathy. J Clin Endocrinol Metab (1973) 1.66
Prognostic factors in the radiotherapy of Graves' ophthalmopathy. Int J Radiat Oncol Biol Phys (1990) 1.65
Survival time of circulating long-acting thyroid stimulator in neonatal thyrotoxicosis: implications for diagnosis and therapy of the disorder. Pediatrics (1965) 1.39
Reproducibility of thallium-201 myocardial imaging. Circulation (1977) 1.36
HL-A antigens as markers for disease susceptibility and autoimmunity in Graves' disease. J Clin Endocrinol Metab (1974) 1.33
Studies on the pathogenesis of the ophthalmopathy of Graves' disease. J Clin Endocrinol Metab (1967) 1.26
Radioisotopic thyroidolymphography in patients with Graves' disease. J Clin Endocrinol Metab (1970) 1.11
Hyperthyroxinemia in patients with acute psychiatric disorders. Am J Med (1982) 1.10
Clinical experience with sensitive thyrotropin measurements: diagnostic and therapeutic implications. J Nucl Med (1985) 1.08
Screening for bone metastases. Are only scans necessary? JAMA (1975) 1.06
Measurements by competitive binding radioassay of serum anti-microsomal and anti-thyroglobulin antibodies in Graves' disease and other thyroid disorders. J Clin Endocrinol Metab (1971) 1.06
Studies on the pathogenesis of Graves' ophthalmopathy (with some related observations regarding therapy). Recent Prog Horm Res (1975) 1.05
Computed tomography in orbital pseudothumor (idiopathic orbital inflammation). Radiology (1976) 1.04
Review of a 5-year experience with the radiostrontium bone scintiscan. Calif Med (1972) 1.02
Radioisotopic angiocardiography: findings in congenital heart disease. J Nucl Med (1972) 0.98
Allogeneic cytolysis of reconstituted membrane vesicles. Proc Natl Acad Sci U S A (1979) 0.98
Alterations in serum thyrotropin (TSH) and thyroid function following radiotherapy in patients with malignant lymphoma. J Clin Endocrinol Metab (1971) 0.97
Interpolative background subtraction. J Nucl Med (1976) 0.94
Distribution and fate of synthetic lipid vesicles in the mouse: a combined radionuclide and spin label study. Proc Natl Acad Sci U S A (1974) 0.93
The influence of lipid substitution on thyrotropin-receptor interactions in artificial vesicles. Endocrinology (1977) 0.91
In vivo distribution of vesicles loaded with radiopharmaceuticals: a study of different routes of administration. J Nucl Med (1975) 0.91
Radioisotopic angiocardiography. Wide scope of applicability in diagnosis and evaluation of therapy in diseases of the heart and great vessels. Circulation (1971) 0.91
Monoclonal antithyroglobulin antibodies derived from immunizations of mice with human eye muscle and thyroid membranes. J Clin Endocrinol Metab (1986) 0.91
Graves' ophthalmopathy following external neck irradiation for nonthyroidal neoplastic disease. J Clin Endocrinol Metab (1973) 0.90
Studies of an in vitro binding reaction between thyroid microsomes and long acting thyroid stimulator globulin (LATS). I. Development of solid-state competitive binding radioassay methods for measurement of antimicrosomal and antithyroglobuin antibodies. J Clin Endocrinol Metab (1970) 0.89
Should a woman taking propylthiouracil breast-feed? Clin Nucl Med (1986) 0.89
HL-A antigens in Japanese Patients with Graves' disease. Tissue Antigens (1975) 0.89
Unruptured aneurysm of the sinus of valsalva producing right ventricular outflow obstruction. Am J Med (1972) 0.88
Computed tomography in Graves' ophthalmopathy. Radiology (1976) 0.88
Thyroglobulin-independent, cell-mediated cytotoxicity of human eye muscle cells in tissue culture by lymphocytes of a patient with Graves' ophthalmopathy. Life Sci (1983) 0.88
Technetium-99m pyrophosphate myocardial uptake in patients with stable angina pectoris. Am J Cardiol (1977) 0.88
Cell-mediated lysis of lipid vesicles containing eye muscle protein: implications regarding pathogenesis of Graves ophthalmopathy. Proc Natl Acad Sci U S A (1979) 0.87
Treatment of orbital pseudotumor (idiopathic orbital inflammation) by radiation therapy. Int J Radiat Oncol Biol Phys (1980) 0.87
Inactivation of long-acting thyroid stimulator (LATS) by anti-kappa and anti-lambda antisera. J Clin Endocrinol Metab (1968) 0.85
Radiometric measurement of thyroglobulin-antithyroglobulin immune complex in human serum. J Clin Endocrinol Metab (1977) 0.85
Sounding board: On white coats and other matters. N Engl J Med (1975) 0.85
The long-acting thyroid stimulator and thyroid disease. Adv Intern Med (1970) 0.84
The diagnosis of intracardiac metastasis of colon carcinoma by radioisotopic and roentgenographic studies. Am J Cardiol (1970) 0.83
Immunoradiometric assay for serum thyroglobulin: semiquantitative measurement of thyroglobulin in antithyroglobulin-positive sera. J Clin Endocrinol Metab (1979) 0.83
Helper and suppressor activities of lymphocyte subsets on antithyroglobulin production in vitro. J Clin Endocrinol Metab (1985) 0.82
Tc99m labelled toluidine blue O for liver scintillography. Int J Appl Radiat Isot (1968) 0.81
Purification of human anti-thyroglobulin. J Clin Endocrinol Metab (1975) 0.81
Radioimmunoassay of free thyroxine in serum: comparison with clinical findings and results of conventional thyroid-function tests. Clin Chem (1980) 0.81
Free thyroxine by solid phase radioimmunoassay: improvement in the laboratory diagnosis of thyroid status in severely ill patients. Clin Chim Acta (1982) 0.80
Radiotherapy of lymphoid diseases of the orbit. Int J Radiat Oncol Biol Phys (1985) 0.80
Combined superior vena cava obstruction and pericardial effusion demonstrated by radioisotopic angiocardiography. J Nucl Med (1970) 0.80
In vitro stimulation by long-acting thyroid stimulator of thyroid glucose oxidation and 32P incorporation into phospholipids. J Clin Invest (1968) 0.79
Effect of heparin on serum free thyroxine linked to post-heparin lipolytic activity. Clin Endocrinol (Oxf) (1983) 0.79
Radioisotopic angiocardiography. Preoperative and postoperative evaluation of patients with diseases of the heart and aorta. Radiol Clin North Am (1971) 0.79
Peripheral blood lymphocytes from normal individuals can be induced to secrete immunoglobulin G antibodies against self-antigen thyroglobulin in vitro. J Clin Endocrinol Metab (1985) 0.79
Performance criteria for appropriate characterization of "(highly) sensitive" thyrotropin assays. Clin Chem (1987) 0.79
Membrane-binding antibodies in patients with Graves' disease and other autoimmune diseases. J Clin Endocrinol Metab (1982) 0.79
Vesicle interactions with polyamino acids and antibody: in vitro and in vivo studies. J Nucl Med (1975) 0.78
Distribution and scintiphotography of a new complex, pentavalent technetium-99m citrate: studies in the rodent. J Nucl Med (1967) 0.78
Therapy with occlusive dressings of pretibial myxedema with fluocinolone acetonide. J Clin Endocrinol Metab (1967) 0.77
Alteration of mammalian cells by interaction with artificial lipid vesicles. Cancer Res (1976) 0.77
New thoughts about the cause and treatment of the severe ocular manifestations of Graves' disease. Scott Med J (1974) 0.77
The long-acting thyroid stimulator. Calif Med (1968) 0.76
Gallium-67 citrate scanning in Hodgkin's disease and non-Hodgkin's lymphoma. Cancer (1976) 0.76
Treatment of exophthalmos and pretibial myxoedema with plasmapheresis. Br Med J (1979) 0.75
Editorial: Hyperthyroidism. Calif Med (1970) 0.75
Simple evaluation of thyroid function. West J Med (1988) 0.75
Degradation of C14-labeled thymidine and its halogenated analogues in man. Adv Tracer Methodol (1966) 0.75
Guidelines and criteria for a committee authorizing the use of radioactive isotopes in humans. J Nucl Med (1967) 0.75
Preparation and binding of antimicrosomal antibody-free LATS, and the effect of iodination on LATS biological activity. J Clin Endocrinol Metab (1971) 0.75
An improved assay for thyrotropin-binding blocking activity in serum of patients with Graves' disease. J Endocrinol Invest (1984) 0.75
[Proceedings: Binding of thyroglobulin and thyroglobulin-antithyroglobulin immune complex with the membrane fraction of the extraocular muscle]. Nihon Naibunpi Gakkai Zasshi (1974) 0.75
Follow-up of patients with differentiated thyroid cancer using serum thyroglobulin measured by an immunoradiometric assay. Comparison with I-131 total body scans. J Nucl Med (1980) 0.75
Re: Clinical assessment of a radioimmunoassay for free thyroxine using a modified tracer. J Nucl Med (1984) 0.75
Reliability and reproducibility of interpretation of 99mtechnetium pyrophosphate myocardial scintigrams. Clin Cardiol (1979) 0.75
Congressional Image of NIH. Science (1963) 0.75
Distribution and scintiphotography of a new lung-scanning agent, 99mTc-macroaggregated thionin: studies in the rodent. J Nucl Med (1969) 0.75
Significance of thyroid dysfunction in human cardiac allograft procurement. Transplantation (1987) 0.75
Letter: Orbital radiotherapy for the ophthalmopathy of Graves's disease. N Engl J Med (1974) 0.75
Albumin-loading effect: a pitfall in saline paper analysis of 99mTc-albumin. J Nucl Med (1974) 0.75
Diagnosis of pericardial effusion by radioisotopic angiocardiography. J Nucl Med (1969) 0.75
Distribution and scintiphotography studies of 99mTc-iron colloid in the rabbit. J Nucl Med (1969) 0.75
Effect of interassay precision on diagnostic accuracy. Clin Chem (1988) 0.75
Video instrumentation for radionuclide angiocardiography. Am J Cardiol (1973) 0.75
Free thyroxine results are affected by albumin concentration and nonthyroidal illness. Clin Chim Acta (1983) 0.75
The accuracy of 111InCl3 as a bone marrow scanning agent. Radiology (1976) 0.75
Biological activity of autoantibodies associated with Graves' dermopathy. J Clin Endocrinol Metab (1989) 0.75
Selective, symmetric, skeletal muscle uptake of Tc-99m pyrophosphate in rhabdomyolysis. Clin Nucl Med (1985) 0.75
Vesicle interactions with antibody and peptide hormone: role of vesicle composition. J Nucl Med (1976) 0.75
Robert Reid Newell, 1892-1965. J Nucl Med (1966) 0.75
Diagnosis of congenital and acquired cardiovascular diseases by radioisotopic angiocardiography. Trans Assoc Am Physicians (1969) 0.75
Serum free thyroxine values in term, premature, and sick infants. J Pediatr (1982) 0.75
Technetium-99m(V)-citrate complex for estimation of glomerular filtration rate. Nature (1967) 0.75
Variable time-lapse videoscintiscope: a modification of the scintillation camera designed for rapid flow studies. J Nucl Med (1969) 0.75
Radioisotopic angiocardiography: findings in mitral stenosis and mitral insufficiency. J Nucl Med (1970) 0.75
Differences in radioimmunoassay results for thyroglobulin that affect management of patients with thyroid cancer. Clin Chem (1984) 0.75
Disparate effects of heparin on free thyroxine as measured by two radioimmunoassays: concise communication. J Nucl Med (1982) 0.75
Indium bone marrow scintigraphy as an aid in selecting marrow biopsy sites for the evaluation of marrow elements in patients with lymphoma. Cancer (1976) 0.75